---
category: listing
circular_id: 45bb949f8dd91596
date: '2025-10-13'
description: Welcure Drugs & Pharmaceuticals Limited announces bonus issue of 1:10
  ratio with deemed allotment date of October 17, 2025 and effective listing date
  of October 20, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={3C3DA1FB-1ED9-4B0A-88D6-CCB68823849F}&noticeno=20251013-18&dt=10/13/2025&icount=18&totcount=62&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Bonus issue in 1:10 ratio increases paid-up capital by 10% from Rs.
  112.36 crore to Rs. 123.59 crore, affecting existing shareholders through additional
  share allotment.
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251013-18&attachedId=7a47165d-fb87-4430-8662-48b2b007a3bf
processing:
  attempts: 1
  content_hash: 6638a6c2ed891f76
  processed_at: '2025-10-13T15:43:43.974895'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-10-13T13:00:20+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={3C3DA1FB-1ED9-4B0A-88D6-CCB68823849F}&noticeno=20251013-18&dt=10/13/2025&icount=18&totcount=62&flag=0
severity: medium
source: bse
stocks:
- WELCURE
tags:
- bonus-issue
- equity-shares
- corporate-action
- capital-restructuring
- WELCURE
title: Sub-Division and Bonus Issue of Equity Shares of Welcure Drugs & Pharmaceuticals
  Limited
---

## Summary

Welcure Drugs & Pharmaceuticals Limited (Scrip Code: 524661) has announced a bonus issue of equity shares in the ratio of 1:10. The company will issue 1,12,35,820 new equity shares of face value Rs. 10 each. The deemed date of allotment is October 17, 2025, with effective listing date of October 20, 2025. The Board of Directors approved the bonus issue on September 27, 2025, following shareholder approval on August 22, 2025.

## Key Points

- **Scrip Code:** 524661
- **ISIN:** INE331C01017
- **Bonus Ratio:** 1:10 (1 new share for every 10 existing shares)
- **New Shares Issued:** 1,12,35,820 equity shares
- **Face Value:** Rs. 10 per share
- **Distribution Number Range:** 11,23,58,201 to 12,35,94,020
- **No Reservation or Abeyance:** No bonus shares are reserved or kept in abeyance

## Regulatory Changes

No regulatory changes are introduced by this circular. This is a standard corporate action notification for bonus share issuance.

## Compliance Requirements

- The company has completed Board of Directors approval and shareholder approval as required for bonus issue
- Contact person for queries: Chintan Didawala Ganpat (Managing Director)
- Contact: 9662323244, welcuredrugs227@gmail.com
- Registered Office: Plot No. 55, Office No. 104, First Floor, Vijay Block, Laxmi Nagar, East Delhi, New Delhi, 110092

## Important Dates

- **August 22, 2025:** Shareholder approval for bonus issue
- **September 27, 2025:** Board of Directors approval for bonus issue
- **October 17, 2025:** Deemed date of allotment of bonus shares
- **October 20, 2025:** Effective date of listing of bonus shares

## Impact Assessment

**Capital Structure Impact:**
- **Before Allotment:** 11,23,58,200 equity shares with paid-up capital of Rs. 112.36 crore
- **After Allotment:** 12,35,94,020 equity shares with paid-up capital of Rs. 123.59 crore
- **Increase:** 10% increase in total outstanding shares

**Shareholder Impact:**
Existing shareholders will receive 1 additional share for every 10 shares held, increasing their shareholding by 10% while maintaining proportional ownership. The bonus issue will improve liquidity and affordability of shares without any cash outflow from shareholders.

**Market Impact:**
The share price is expected to adjust proportionately post-bonus issue. Increased number of shares in circulation may enhance trading liquidity.